Puchuang Medical Launches Sonico-CX® Intravascular Lithotripsy System Nationwide with the Theme 'Addressing Calcification, Innovating Cardiology'

Jul 02, 2024 20:08 CST Updated 20:08

Spectrumedics

Developer of Cardiovascular Minimally Invasive Interventional Therapy

*For medical professionals only

From June 27 to 30, 2024, the 18th Oriental Congress of Cardiology and World Congress of Cardiology was grandly held in Shanghai. Spectrumedics, an innovative enterprise in the field of pan-vascular disease intervention, showcased its all-new star product——China-produced Sonico-CX Coronary Shock Wave Treatment System^®）Spectrumedics made a grand appearance at this conference, attracting the attention of many cardiology experts and colleagues!

At noon on June 29, Spectrumedics"Calcification Discussion · Innovating the Future of the Heart —— Intravascular Lithotripsy Balloon Treatment for High-Resistance Lesions Session"The event was successfully held, with active exchanges and in-depth discussions among the attendees, jointly contributing to the vigorous development of China's cardiology事业.

Calcification Theory · Innovate the Future

Launch Ceremony of China-Made Intravascular Shockwave Balloon

In the presence of more than ten experts,"Calcification Discussion · 'Innovate' the Future of the Heart" Spectrumedics China-Made Intravascular Shockwave Balloon Sonico-CX^®China Launch CeremonyStyleSuccessfully held.

Zhongshan Hospital Affiliated to Fudan UniversityAcademician Ge JunboAnd Zhongshan Hospital Affiliated to Fudan UniversityProfessor Juying QianAttended and delivered the opening speech, Zhongshan Hospital Affiliated to Fudan UniversityProfessor Shen LiServe as the host guest.

Prof. Ge Junbo, Academician of Fudan University Zhongshan Hospital

Academician Ge JunboIn his speech, he pointed out that high-resistance or calcified lesions are the types of lesions interventional doctors dread most. This is because, during surgery, while a guidewire can pass through the lesion, a balloon often cannot, making it one of the challenges in vascular interventional treatment. The emergence of the shockwave balloon, much like the "Bone Dissolving Cotton Palm" technique in martial arts, can effectively shatter calcifications within a certain range without affecting normal tissue, thereby successfully dilating the blood vessel. Academician Ge expressed his gratitude to the company for providing interventional doctors with such an effective tool, enabling clinicians to offer better services to patients.

Professor Qian Juying from Zhongshan Hospital, Fudan University

Professor Juying QianIn the speech, it was emphasized that the shockwave balloon works like "hitting a cow through a mountain," using this tool can significantly expand the diseased lumen, thereby achieving excellent therapeutic effects for stent implantation. It is hoped that in the future, we can jointly build a defense line for the prevention and treatment of cardiovascular diseases, and together welcome the turning point of the decline in cardiovascular diseases. We also look forward to the effects of interventional treatment becoming better and better, allowing more patients to benefit from new technologies in interventional treatment.

Experts Witness the Launch Ceremony Together

Subsequently,Calcification Theory · "Innovate" the Future - Spectrumedics China-produced Intravascular Shockwave Balloon Sonico-CX^®China Launch CeremonyOfficially begins, Zhongshan Hospital Affiliated to Fudan UniversityAcademician Ge Junbo, Zhongshan Hospital Affiliated to Fudan UniversityProfessor Juying QianZhongshan Hospital Affiliated to Fudan UniversityProfessor Shen Li, Zhongda Hospital Affiliated to Southeast UniversityProfessor Ma Genshan, Guangdong Provincial People's HospitalProfessor Luo JianfangThe First Affiliated Hospital of University of Science and Technology of ChinaProfessor Ma Likun, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang UniversityProfessor Guosheng Fu, Tongji Hospital, ShanghaiProfessor Xuebo Liu, Shanghai Sixth People's HospitalProfessor Chengxing Shen, Tianjin Chest HospitalProfessor Cong HongliangZhongshan Hospital Affiliated to Fudan UniversityProfessor Lu Hao, Affiliated Hospital of Zunyi Medical UniversityProfessor Shi Bei, Zhongshan Hospital Affiliated to Fudan UniversityProfessor Zhang Feng, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang UniversityProfessor Zhou BinquanAndFounder and CEO of SpectrumedicsDr. Peng HuiqunWitness together. Spectrumedics focuses on the field of heart and vascular treatment, always adhering to the spirit of independent research and development and independent innovation. It strives to solve unresolved clinical problems through cutting-edge technology. In the future, it will continue to deeply cultivate the field of cardiovascular diseases, assist clinicians, and jointly uphold patients' lives.

Academic Exchange

Exploring the Development Path of China-Made Intravascular Shockwave Balloons

(Left) Professor Ma Genshan from Zhongda Hospital Affiliated to Southeast University (Right) Professor Luo Jianfang from Guangdong Provincial People's Hospital

In the keynote speech session, Zhongshan Hospital Affiliated to Fudan UniversityProfessor Shen LiConducting Thematic Sharing, Guangdong Provincial People's HospitalProfessor Luo JianfangAnd Zhongda Hospital Affiliated to Southeast UniversityProfessor Ma GenshanCo-host.

Professor Shen Li from Zhongshan Hospital, Fudan University

Professor Shen LiShared the theme "The Development Path of China-Made Intravascular Shockwave Balloons", he started with the clinical pain point of the increasing number of PCI cases year by year, and then explained the treatment characteristics of IVL technology, guidelines/consensus recommendations, mechanisms of action, safety and effectiveness, as well as innovative case situations.He said that Spectrumedics'Sonico-CX^®Intravascular Lithotripsy SystemIt can achieve the highest number of pulses (120 times) in its class, a smaller folded outer diameter, and a more complete range of specifications and models. It can match coronary vessels more precisely, facilitate better balloon adhesion to the vessel wall, and enhance lithotripsy effectiveness.IVL Technology in China: A Hundred Schools of Thought, but SpectrumedicsSonico-CX^®Intravascular Shockwave Treatment SystemThe innovation itself is uniquely ingenious,With the minimization of balloon crossing profile, the increase in balloon pulse counts, and the uniformity enhancement of balloon deployment range., three unique technical advantages will further rewrite the treatment pathway for calcified lesions in China, increase surgical success rates, reduce surgery-related complications, and improve patient prognosis, bringing good news to a wide range of patients.

During the thematic discussion session, hosted by Guangdong Provincial People's HospitalProfessor Luo JianfangGuiding speech, focusing on two major aspects: pulse release angle (360°) and balloon pulse count (120 times), with Zhongda Hospital Affiliated to Southeast University.Professor Ma GenshanThe First Affiliated Hospital of University of Science and Technology of ChinaProfessor Ma Likun, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang UniversityProfessor Zhou BinquanIn-depth discussions on the challenges and future application development of interventional technology, sparking collisions of new ideas, new concepts, and new perspectives.

Surgical Live Streaming

Tackling Clinical Challenges, Witnessing Technological Charm

Surgical Live Streaming Session,Professors Ge Lei and Lu Hao from the team of Academician Ge Junbo of Zhongshan Hospital Affiliated to Fudan University presented two cases of application of Spectrumedics' Sonico-CX in a live demonstration at the conference.^®Intravascular Shockwave Balloon Successfully Completes First Two Clinical Applications in China for Complex Calcified Lesion Surgery After Product Launch.Sir Run Run Shaw Hospital, School of Medicine, Zhejiang UniversityProfessor Guosheng Fu, Tongji Hospital, ShanghaiProfessor Xuebo LiuAnd Zhongshan Hospital Affiliated to Fudan UniversityProfessor Juying QianCo-chaired by Shanghai Sixth People's HospitalProfessor Shen Chengxing, Affiliated Hospital of Zunyi Medical UniversityProfessor Shi Bei, Zhongshan Hospital Affiliated to Fudan UniversityProfessor Zhang FengParticipate in the discussion.

Surgical Live Broadcast 1:

Professor Ge Lei's Team: Breakthrough in Technical Barriers - Shockwave Balloon Revolutionizes Therapy, Perfectly Solving the Problem of Incomplete Stent Expansion

Patient underwent coronary artery plaque atherectomy and stent implantation three months ago due to coronary stenosis. The stent showed suboptimal expansion with a risk of sudden occlusion leading to acute myocardial infarction. Professor Ge Lei's team discussed the use of percutaneous intravascular lithotripsy balloon catheter angioplasty (IVL) to address the issue of incomplete stent expansion.

➤ Case Characteristics: Poor Rotablation Effect, Incomplete Stent Expansion.

Coronary Basic Angiography:The original stent in the proximal and middle segments of the anterior descending artery is in place, with an 80% narrowing due to a proximal tubular lesion within the stent.(Figure 1).

Figure 1 Coronary Angiography Image

Select 3.0×12mm Sonico-CX^®After 6 rounds (10 pulses/round) of shockwave treatment with the shockwave balloon, significant improvement in stent expansion was observed.(Figure 2).

Figure 2 Before/After IVL Treatment

OCT Examination (Preoperative):Incomplete expansion at the site of in-stent restenosis with calcification outside the stent, minimum stent expansion rate 24%.(Figure 3).

Figure 3: Pre-treatment - Stent Expansion Rate

Immediate OCT Recheck (After IVL):Minimum stent expansion rate increased to 72%(Figure 4).

Figure 4 Immediate Post-IVL - Stent Expansion Rate

OCT Review (Postoperative) ShowsMinimum stent expansion rate increased to 89%(Figure 5).

Figure 5: Post-treatment stent expansion rate

The overall postoperative effect was significant, with satisfactory stent expansion, no residual stenosis, and distal TIMI grade 3 flow (Figure 6).

Figure 6 Preoperative/Postoperative

Surgical Live Broadcast II:

Professor Lu Hao's Team: Groundbreaking Breakthrough - Shockwave Balloon UsHers in a New Era for Calcified Lesion Treatment, Eliminating Circular Calcification and Calcified Nodules

The patient's left anterior descending artery had circular calcified lesions accompanied by calcified nodules. The effect of high-pressure balloon angioplasty was poor, and the long-term patency rate was less than ideal. Professor Lu Hao's team discussed using percutaneous coronary intravascular lithotripsy balloon catheter angioplasty (IVL) to treat the calcified stenotic lesions in the proximal and middle segments of the left anterior descending artery.

➤ Case Characteristics: Annular Calcification, Calcified Nodule

Coronary Basic Angiography:Diffuse lesion in the mid-LAD with 80% stenosis and severe calcification(Figure 7).

Figure 7 Coronary Angiography Image

Select 3.0×12mmSonico-CX^®ImpactWave Balloon, respectively, in the proximal and middle segments of the anterior descending branch: 1, calcified nodular lesions were treated at4 roundsShockwave therapy (Fig. 8); and 2, severe circumferential calcification6 rounds (100 pulses in total)Adequate balloon expansion was achieved after shock wave treatment (Figure 9).

Figure 8 Calcified Nodule: Before/After IVL Treatment

Figure 9 Severe Circular Calcification: Before/After IVL Treatment

OCT Examination (Preoperative):Diffuse (long) calcified lesion in the proximal to middle segment of the left anterior descending artery, including: localized calcified nodules (the "root cause" of suboptimal balloon expansion) and severe circumferential calcification (wall thickness 1.24mm).

Immediate OCT复查 (after IVL) showed significant improvement in lumen diameter.

Calcified Nodule OCT Preoperative Examination

Preoperative OCT Examination for Annular Calcification

OCT Image Immediately After IVL

The overall postoperative stent expansion was satisfactory, with no residual stenosis, and the forward blood flow was TIMI grade 3 (Figure 10).

Figure 10: Preoperative/Postoperative

Sonico-CX^®Dazzling Debut!

Powerfully Assisting in the Interventional Treatment of Coronary Heart Disease

Spectrumedics' Coronary Shock Wave Treatment System Made a Significant Debut During the Conference. It is Currently the Only Intravascular Coronary Shock Wave Treatment Product that is Independently Developed in China, Granted an Invention Patent, and Successfully Overcomes the Technical Bottlenecks of Similar Foreign Products.

Coronary Shockwave Treatment System by Sonico-CX^®Composed of a single-use coronary intravascular lithotripsy catheter (NMPA approval No. 20243010464) and an intravascular lithotripsy treatment device (NMPA approval No. 20243010505), this is a revolutionary dedicated device for Intravascular Lithotripsy (IVL), a percutaneous coronary intravascular lithotripsy energy calcification fragmentation procedure. With the popularization and application of this product, it not only brings good news to patients with coronary calcification but also advances cardiovascular clinical treatment into a whole new era!

During the conference, the core product displayed at the Spectrumedics booth - the Coronary Shock Wave Treatment System (Sonico-CX)^®) Becoming one of the highlights of the exhibition, attracting many industry peers to visit.Prof. Ge Junbo, Academician of Fudan University Zhongshan HospitalVisit and guide at the booth in person, the on-site enthusiasm continues to rise!

Booth Photo

Booth Product Photos (Swipe left and right to view)

On-site Quick Cut of the Conference

Technology Leads the Way, Forging Ahead, Discussing Calcification, Creating a "Heart" Future. This conference fully showcased Spectrumedics.Coronary Shock Wave Treatment System (Sonico-CX)^®）The technological innovation landscape has opened more windows for the innovative development of interventional technologies. As a platform-based innovative medical technology enterprise focusing on active minimally invasive interventional technologies for cardiac and泛血管 (pan-vascular) applications, Spectrumedics always centers on the operator, actively continuing its innovative research and development. It is committed to providing clinical doctors with more effective innovative solutions for treating cardiovascular diseases, benefiting more patients. It is believed that in the future, through continuous improvement, China's interventional事业 (cause) will surely achieve its prosperity with a daily renewal momentum.

More Exciting Content on Cardiovascular

Come quickly “Doctor Station NetworkPage Edition"Take a look?"

Long press to scan the QR code

Exciting Information Awaits You

*"Medical Community" strives to ensure that the content published is professional and reliable, but does not guarantee the accuracy of the content; relevant parties should verify independently when adopting it or using it as a basis for decision-making.

Click "Read the original text"`, learn more clinical skills`